The Study of Abatacept in Combination With Etanercept

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan

NCT00688103 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

NCT00706797 ·Status: TERMINATED ·Phase: PHASE4

Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice

NCT01692899 ·Status: COMPLETED

Remission Induction in Very Early Rheumatoid Arthritis

NCT00523692 ·Status: UNKNOWN ·Phase: PHASE4

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis

NCT01299961 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

NCT00244556 ·Status: COMPLETED ·Phase: PHASE4

Long Term Experience With Abatacept in Routine Clinical Practice

NCT02109666 ·Status: COMPLETED

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00565409 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects

NCT00252668 ·Status: COMPLETED ·Phase: PHASE4

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis

NCT03332719 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

NCT01927757 ·Status: TERMINATED ·Phase: PHASE4

Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia

NCT02778906 ·Status: COMPLETED ·Phase: PHASE3

Long-term Experience With Abatacept SC in Routine Clinical Practice

NCT02090556 ·Status: COMPLETED

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

NCT00522184 ·Status: COMPLETED ·Phase: PHASE3

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

NCT00767325 ·Status: COMPLETED ·Phase: PHASE3

Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)

NCT01313208 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

NCT00484237 ·Status: COMPLETED ·Phase: PHASE3

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

NCT02373813 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes

NCT01258738 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

NCT00393471 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

NCT01895309 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis

NCT00783536 ·Status: WITHDRAWN ·Phase: PHASE4

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

NCT00520572 ·Status: COMPLETED ·Phase: PHASE2